50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Normal Karyotype Acute Myeloid Leukemia

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Normal Karyotype Acute Myeloid Leukemia

Saturday, December 6, 2008: 2:00 PM-3:30 PM

Yerba Buena Ballroom Salon 9 (San Francisco Marriott)

Sunday, December 7, 2008: 9:30 AM-11:00 AM

Yerba Buena Ballroom Salon 9 (San Francisco Marriott)

Importance of FLT3 Mutations and Other Genetic Abnormalities in Normal Karyotype AML

Clara D. Bloomfield, MD¹ and Guido Marcucci, MD²

¹The Ohio State University, Columbus, OH
²James Cancer Hospital, The Ohio State University Medical Center, Columbus, OH

Uncovering AML Subtypes and Their Biology: Applying Genome-Wide Profiling

Ruud Delwel, PhD

Erasmus University Medical Center, Rotterdam, Netherlands

Role of Nucleophosmin Mutations in AML

Kotaro Funato, MD, PhD¹^* and David W. Sternberg, MD, PhD²

¹Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, NY
²Mount Sinai School of Medicine, New York, NY

See more of: Scientific Program

<< Previous Session | Next Session >>